Abstract

BackgroundDepression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression.MethodsMale NHS participants with available ICD-9 data for mental health diagnoses, Center for Epidemiological Studies Depression (CES-D) measures, and self-reported adherence (SRA) were included. ART use was defined as ART initiation between 2006 and 2010, with follow-up through 2015. SRA was defined as taking 95% of ART doses and continuous ART was defined as longitudinal ART use with gaps < 30 days. Continuous VL suppression was defined as maintaining VLs < 200 c/mL on ART. To analyse the association between depression and HIV treatment outcomes, latent class analysis was used to create classes of depression trajectories: low depression (LD), recent onset depression (ROD) and high Depression (HD).ResultsParticipants had a mean age of 32 (± 8.3) years at HIV diagnosis, and similar proportions were Caucasian (44.3%) or African American (40.8%). Overall, older participants at HIV diagnosis had greater odds of having 95% self-reported adherence (OR 1.06, 95% CI 1.02–1.12), and African Americans had lower odds (OR 0.41, 95% CI 0.22–0.76) compared to Caucasians (OR 1.49, 95% CI 0.52–4.28). However, there was no difference in SRA by depression trajectory. Participants with HD had an increased odds of taking ART continuously (OR 1.75, 95% CI 0.99–3.09), and those with ROD had significantly higher odds of virologic failure (OR 0.58, 95% CI 0.38–0.91).ConclusionsAlthough there was no observed association between depression and SRA, participants with ROD had lower odds of attaining the HIV treatment goal of VL suppression. Continued efforts to identify and aggressively manage mental health disorders is important to success along the HIV care continuum.

Highlights

  • Adherence to antiretroviral therapy (ART) is essential for the achievement and long-term maintenance of viral suppression in people living with HIV (PLWH)

  • The mean age at HIV diagnosis for the 549 participants included in this study was 32 years, and similar proportions were Caucasian (44%) and African American (41%), with those in the Other category representing a smaller portion of the sample

  • Participants with increased age at HIV diagnosis had higher odds of having 95% self-reported adherence (SRA) while African Americans, compared to Caucasians, had significantly lower odds in our study Table 2

Read more

Summary

Introduction

Adherence to antiretroviral therapy (ART) is essential for the achievement and long-term maintenance of viral suppression in people living with HIV (PLWH). Carney et al AIDS Res Ther (2021) 18:29 mental health diagnoses such as depression may negatively influence adherence to ART, resulting in failed viral suppression. A previous study reported that treatment-naïve patients with mental health disorders had slower rates of virologic suppression after ART initiation [7]. The potential impact of depression on ART adherence has been evaluated in previous studies. Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call